Behind the landmark WHO decision on essential medicines for MS
Multiple sclerosis (MS) treatments have been successfully added onto the World Health Organisation's Essential Medicines List (EML) in July 2023. Nick Rijke of the MS International Federation and Dean...
21 Syys 202331min
Women with MS
MS affects more women than men. Research on the reasons behind this, and if and how sex-specific processes may impact disease progression, and the symptoms experienced by women living with MS continue...
10 Elo 202327min
Utilising Global Data Registries for MS Research
The development of global databases that record and store large amounts of clinical data for people living with MS has made a significant difference to the MS research world. In this episode, we talk...
29 Kesä 202335min
Epstein-Barr Virus and Multiple Sclerosis
A longitudinal study published in 2022 found that infection with the Epstein-Barr virus (EBV) dramatically increased the risk of developing multiple sclerosis, suggesting that MS is likely caused by E...
24 Touko 202322min
Access For All: Adding MS DMTs to the WHO Essential Medicines List
Everyone with MS should have access to the treatment and care that they need. Yet in 70% of countries, people face huge challenges in accessing disease modifying therapies (DMTs). Nick Rijke with the ...
12 Huhti 202319min
Using Real-World Studies to Compare DMTs in MS
Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, and Maria Pia Sormani, Professor of Biostatistics at the University of Genoa, discuss the use of real-world ...
29 Maalis 202324min
Remyelination in MS: a New Clinical Trial
Will Brown and Alasdair Coles from University of Cambridge discuss remyelination in multiple sclerosis and a promising clinical trial that they are currently involved in.
6 Maalis 202324min
Stem Cell Research in Multiple Sclerosis
Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, explains his research comparing hematopoietic stem cell transplantation (HSCT) with existing treatments in r...
24 Tammi 202321min
